Literature DB >> 16754648

Batten disease: features to facilitate early diagnosis.

J Collins1, G E Holder, H Herbert, G G W Adams.   

Abstract

AIMS: To ascertain the clinical and electrophysiological features in patients with juvenile neuronal ceroid lipofuscinosis (jNCL/Batten disease) and to identify those features that facilitate early diagnosis.
METHODS: Nine patients with jNCL were identified retrospectively and their case notes reviewed. All had undergone an extensive clinical examination, including electrophysiology. Blood and molecular genetic testing confirmed the diagnosis.
RESULTS: Age at onset ranged from 4-8 years. At presentation, two of nine patients had normal fundi; only two of nine patients had a bull's eye maculopathy. The electroretinogram (ERG) findings in this series included undetectable rod specific ERGs, an electronegative maximal response, reduced and delayed cone flicker ERGs, reduction in the b:a ratio in the photopic single flash ERG, and an undetectable pattern ERG. Vacuolated lymphocytes on peripheral blood film testing were present in eight of nine patients. Five of eight patients were homozygous for the 1.02 kb deletion on the CLN3 gene on molecular genetic testing; two of eight patients were heterozygous for that deletion.
CONCLUSION: jNCL should be considered in children of 10 years and under presenting with visual loss and fundal changes ranging from normal through to pigmentary/atrophic changes or a bull's eye maculopathy. Electrophysiology may suggest jNCL. Although currently untreatable, early diagnosis is important to institute appropriate counselling and support.

Entities:  

Mesh:

Year:  2006        PMID: 16754648      PMCID: PMC1857407          DOI: 10.1136/bjo.2006.091637

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Batten disease--deteriorating course of ocular findings.

Authors:  M Horiguchi; Y Miyake
Journal:  Jpn J Ophthalmol       Date:  1992       Impact factor: 2.447

2.  Duane's retraction syndrome and juvenile Batten's disease: a new association?

Authors:  W E Marshman; J P Lee; B Jones; G Schalit; G E Holder
Journal:  Aust N Z J Ophthalmol       Date:  1998-08

3.  Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.

Authors: 
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

4.  Refsum disease: the presentation and ophthalmic aspects of Refsum disease in a series of 23 patients.

Authors:  K G Claridge; F B Gibberd; M C Sidey
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

Review 5.  The intracellular location and function of proteins of neuronal ceroid lipofuscinoses.

Authors:  Junji Ezaki; Eiki Kominami
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

Review 6.  The genetic spectrum of human neuronal ceroid-lipofuscinoses.

Authors:  Sara E Mole
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

7.  Juvenile Batten's disease: an ophthalmological assessment of 26 patients.

Authors:  D J Spalton; D S Taylor; M D Sanders
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

8.  Neuronal ceroid lipofuscinosis: a clinicopathological study.

Authors:  Sanjib Sinha; P Satishchandra; Vani Santosh; N Gayatri; S K Shankar
Journal:  Seizure       Date:  2004-06       Impact factor: 3.184

Review 9.  The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses.

Authors:  R G Weleber
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

10.  Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.

Authors:  I Mantel; M A Brantley; C Bellmann; A G Robson; G E Holder; A Taylor; G Anderson; A T Moore
Journal:  Klin Monbl Augenheilkd       Date:  2004-05       Impact factor: 0.700

View more
  22 in total

1.  A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.

Authors:  Naser Gilani; Ehsan Razmara; Mehmet Ozaslan; Ihsan Kareem Abdulzahra; Saeid Arzhang; Ali Reza Tavasoli; Masoud Garshasbi
Journal:  Acta Neurol Belg       Date:  2021-03-30       Impact factor: 2.396

2.  Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Authors:  Fred K Chen; Xiao Zhang; Jonathan Eintracht; Dan Zhang; Sukanya Arunachalam; Jennifer A Thompson; Enid Chelva; Dominic Mallon; Shang-Chih Chen; Terri McLaren; Tina Lamey; John De Roach; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2018-11-16       Impact factor: 2.379

3.  Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.

Authors:  Sophia-Martha Kleine Holthaus; Mikel Aristorena; Ryea Maswood; Olha Semenyuk; Justin Hoke; Aura Hare; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Hum Gene Ther       Date:  2020-07       Impact factor: 5.695

4.  Topological Alterations of the Structural Brain Connectivity Network in Children with Juvenile Neuronal Ceroid Lipofuscinosis.

Authors:  T Roine; U Roine; A Tokola; M H Balk; M Mannerkoski; L Åberg; T Lönnqvist; T Autti
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

Review 5.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 6.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

7.  Prevention of Photoreceptor Cell Loss in a Cln6nclf Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells.

Authors:  Sophia-Martha Kleine Holthaus; Joana Ribeiro; Laura Abelleira-Hervas; Rachael A Pearson; Yanai Duran; Anastasios Georgiadis; Robert D Sampson; Matteo Rizzi; Justin Hoke; Ryea Maswood; Selina Azam; Ulrich F O Luhmann; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Mol Ther       Date:  2018-03-02       Impact factor: 11.454

8.  Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease.

Authors:  Kyle D Kovacs; Samir Patel; Anton Orlin; Keunpyo Kim; Sherri Van Everen; Therese Conner; Dolan Sondhi; Stephen M Kaminsky; Donald J D'Amico; Ronald G Crystal; Szilárd Kiss
Journal:  Ophthalmol Retina       Date:  2020-01-22

9.  BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.

Authors:  Tatyana I Metelitsina; Darrel J Waggoner; Michael A Grassi
Journal:  Retin Cases Brief Rep       Date:  2016

Review 10.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.